Related Experiment Video

Updated: Aug 13, 2026

New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells
06:34

New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells

Published on: October 9, 2017

Phototherapy for neonatal jaundice in erythrocyte glucose-6-phosphate dehydrogenase-deficient infants

K L Tan

    Pediatrics
    |June 1, 1977
    PubMed

    Insights

    Phototherapy effectively manages neonatal hyperbilirubinemia in infants with glucose-6-phosphate dehydrogenase (G6PD) deficiency. It prevents bilirubin rise and aids treatment without causing hemolysis, even with prolonged use.

    Area of Science:

    • Neonatal Medicine
    • Pediatric Hematology
    • Phototherapy Research

    Background:

    • Neonatal hyperbilirubinemia is a common condition.
    • Glucose-6-phosphate dehydrogenase (G6PD) deficiency increases risk.
    • Effective management strategies are crucial for infant health.

    Purpose of the Study:

    • To evaluate phototherapy's efficacy in G6PD-deficient neonates.
    • To compare prophylactic and therapeutic phototherapy.
    • To assess phototherapy's impact on hemoglobin levels and hemolysis.

    Main Methods:

    • Studied "prophylactic" phototherapy (6 days) in 12 G6PD-deficient infants.
    • Compared outcomes with a control group of G6PD-deficient infants.
    • Assessed "therapeutic" phototherapy in 48 infants (24 nonhemolytic, 24 G6PD-deficient).

    Main Results:

    • Prophylactic phototherapy prevented significant bilirubin rise in G6PD-deficient infants during the first three days.
    • Hemoglobin levels remained comparable between groups.
    • Therapeutic phototherapy effectively reduced bilirubin in both nonhemolytic and G6PD-deficient hyperbilirubinemia cases.

    Conclusions:

    • Phototherapy is efficacious for preventing and treating neonatal hyperbilirubinemia in G6PD-deficient infants.
    • Prolonged phototherapy does not induce hemolysis in these infants.
    • Phototherapy offers a safe and effective management option for this population.

    More Related Videos

    How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

    How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

    Published on: August 19, 2020

    Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina07:04

    Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina

    Published on: March 14, 2025

    Related Concept Videos

    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Jaundice01:25

    Jaundice

    Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...